A change of PD-1/PD-L1 expression on peripheral T cell subsets correlates with the different stages of Alzheimer's Disease

White MR(2014)Alzheimer's associated beta-amyloid protein inhibits influenza A virus and modulates viral interactions with phagocytes PLoS ONE 9 870-881

Kandel R(2013)Vascular oxidative stress and mitochondrial failure in the pathobiology of Alzheimer's disease: a new approach to therapy CNS Neurol Disord Drug Targets 12 291-296

Tripathi S(2010)The, "LEARn" (Latent Early-life Associated Regulation) model integrates environmental risk factors and the developmental basis of Alzheimer's disease, and proposes remedial steps Exp Gerontol 45 10075-10078

Condon D(1992)Cholinergic agonists and interleukin 1 regulate processing and secretion of the Alzheimer beta/A4 amyloid protein precursor Proc Natl Acad Sci USA 89 7611-7615

Qi L(1989)Brain interleukin 1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease Proc Natl Acad Sci USA 86 318-320

Taubenberger J(1991)Elevated circulating tumor necrosis factor levels in Alzheimer's disease Neurosci Lett 129 23-26

Sochocka M(1994)Demonstration of CRP immunoreactivity in brains of Alzheimer's disease: immunohistochemical study using formic acid pretreatment of tissue sections Neurosci Lett 177 821-836

Koutsouraki ES(1999)Brain inflammation in Alzheimer disease and the therapeutic implications Curr Pharm Des 5 799-809

Gasiorowski K(2001)Inflammation, autotoxicity and Alzheimer disease Neurobiol Aging 22 2043-2062

Leszek J(2001)Factors modifying the migration of lymphocytes across the blood-brain barrier Int Immunopharmacol 1 201-178

White MR(2014)Alzheimer's associated beta-amyloid protein inhibits influenza A virus and modulates viral interactions with phagocytes PLoS ONE 9 870-881

Kandel R(2013)Vascular oxidative stress and mitochondrial failure in the pathobiology of Alzheimer's disease: a new approach to therapy CNS Neurol Disord Drug Targets 12 291-296

Tripathi S(2010)The, "LEARn" (Latent Early-life Associated Regulation) model integrates environmental risk factors and the developmental basis of Alzheimer's disease, and proposes remedial steps Exp Gerontol 45 10075-10078

Condon D(1992)Cholinergic agonists and interleukin 1 regulate processing and secretion of the Alzheimer beta/A4 amyloid protein precursor Proc Natl Acad Sci USA 89 7611-7615

Qi L(1989)Brain interleukin 1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease Proc Natl Acad Sci USA 86 318-320

Taubenberger J(1991)Elevated circulating tumor necrosis factor levels in Alzheimer's disease Neurosci Lett 129 23-26

Sochocka M(1994)Demonstration of CRP immunoreactivity in brains of Alzheimer's disease: immunohistochemical study using formic acid pretreatment of tissue sections Neurosci Lett 177 821-836

Koutsouraki ES(1999)Brain inflammation in Alzheimer disease and the therapeutic implications Curr Pharm Des 5 799-809

Gasiorowski K(2001)Inflammation, autotoxicity and Alzheimer disease Neurobiol Aging 22 2043-2062

Leszek J(2001)Factors modifying the migration of lymphocytes across the blood-brain barrier Int Immunopharmacol 1 201-178